Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection
Clinical trial NCT04765449 · COMPLETED
Trial details
- NCT number
- NCT04765449
- Sponsor
- Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2022-07-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.